The White House proposed major budget cuts to US science agencies, including a 13% reduction for the National Institutes of Health and cuts exceeding 50% for the NSF and EPA compared with current levels in 2027. The plan also seeks to ban using federal funds for subscriptions and publishing fees for some academic journals. The proposal would slash NSF’s budget by nearly 55%, while maintaining quantum and AI funding at the highest level among the areas mentioned, though the plan still targets reductions for basic research at NSF. According to tracking cited in the report, those changes would materially affect health and biomedical research pipelines. While Congress ultimately decides budget levels, the administration’s document sets the opening line for negotiations. The timing is critical, because federal appropriations can take months and the plan could shift during congressional bargaining. For biotech stakeholders who rely on academic research ecosystems, federal funding stability is a direct input to grant availability, translational partnerships, and early-stage innovation capacity.